Personalized Medicine
Personalized medicine, also known as precision medicine, represents a new approach to healthcare that tailors clinical treatment to the patient’s characteristics. This approach moves away from the ” one-size-fits-all ” model, recognizing that each individual responds differently to the same treatment due to the variation of their genes, environment, and lifestyle. Personalized medicine involves genetic testing, biomarkers, and advanced data analytics to understand the specific patient’s biological makeup, allowing for more accurate diagnoses, disease risk prediction, and customized treatment plans. This can lead to more efficient treatments with fewer adverse effects, particularly in areas like oncology, where genetic information can guide the selection of specific drugs targeting cancer cell mutations. Personalized medicine also expands into other fields, including psychiatry, cardiology, and infectious diseases, offering the promise of more precise, predictive, and preventive healthcare. The growth of personalized medicine is enabled by advancements in genomics, biotechnology, and data science and is making significant impacts in changing the landscape of medical treatment and patient care.
Personalized Medicine
Latest Posts
-
HLA Inception: A Convolutional Neural Network To Predict MHC-I Peptide Bindings
Arizona State University scientists developed “HLA Inception,” a groundbreaking AI tool using convolutional neural networks to predict MHC-1 peptide bindings. This tool, leveraging molecular electrostatics, offers rapid, proteome-scale predictions, transforming complex analysis processes from days to seconds…
-
Link Between Cellular Metabolism and Depression Uncovered by UC San Diego Study
The University of California San Diego School of Medicine researchers conducted a study that establishes a possible link between cellular metabolism and depression. The research revealed that individuals with depression and suicidal thoughts have specific detectable compounds…
-
Researchers develop ultra thin wearable skin electronics
This latest research by a Japanese academic-industrial collaboration, led by Professor Takao Someya at the University of Tokyo’s Graduate School of Engineering presents a new ultrathin, elastic display that fits snugly on the skin and can show…
-
Collaboration between UCSF, Intel to develop deep learning analytics for healthcare
UC San Francisco’s Center for Digital Health Innovation (CDHI) today announced a collaboration with Intel Corporation to deploy and validate a deep learning analytics platform designed to improve care by helping clinicians make better treatment decisions, predict…
-
New approach to targeted cancer treatment and imaging by utilizing glycosidase activation of glyconaphthalimides.
Scientists from Trinity College Dublin have uncovered a new class of compounds glyconaphthalimides that can be used to target cancer cells with greater specificity than current options allow. The study was published in the journal Chemical Communications. Cervical cancer…
-
New tool to discover bio-markers for aging using In-silico Pathway Activation Network Decomposition Analysis (iPANDA)
Today the Biogerontology Research Foundation announced the international collaboration on signaling pathway perturbation-based transcriptomic biomarkers of aging. On November 16th scientists at the Biogerontology Research Foundation alongside collaborators from Insilico Medicine, Inc, the Johns Hopkins University, Albert…
-
New electrochemical biosensor system that can be used for point-of-care antibiotic testing could usher personalized antibiotic treatment
A team of researchers from the University of Freiburg has developed a system inspired by biology that can detect several different antibiotics in human blood or other fluids at the same time. This biosensor system could be…
You must be logged in to post a comment.